Centum Confident on FY27 Growth After Q1 Phasing

Centum Electronics Limited — Q1 FY27 Earnings Conference Call (held on Aug 14, 2026)

1. Overall Tone of Management: Optimistic

• Management acknowledges Q1 was “somewhat muted compared with our expectations for the full year, both in terms of growth and margins,” but repeatedly ties this to execution/revenue phasing rather than demand weakness.
• Strong confidence language: “we are confident,” “gives us confidence,” “we remain confident,” and “well positioned to deliver” on a full-year basis.
• Clear positive structural event: overseas restructuring/exit is largely completed, enabling “a much sharper focus on our core India ESDM platform.”

2. Key Themes from Management Commentary

• Q1 softness explained by phasing/execution (not fundamentals):
• BTS revenue/margins muted due to “quarterly variations in project execution and revenue phasing.”
• Order book strength and visibility:
• Standalone order book ~INR 1,800 crores (+31% YoY).
• Order inflow in quarter ~INR 360 crores (+70% YoY), with BTS inflow ~150% YoY.
• Overseas restructuring largely “put behind us”:
• French court approval and deconsolidation effective 4 June 2026; liquidation process started 2 July 2026.
• Management states: “we do not expect any further liabilities” from these subsidiaries.
• BTS demand remains strong; revenue growth expected to accelerate:
• BTS order book grew ~40% YoY; management expects “clear strong revenue growth… this year and the coming years.”
• EMS momentum + semiconductor equipment ramp:
• EMS revenue +20% YoY; EMS order book +23% YoY.
• Semiconductor equipment: ramping well; visibility to “surpass our current expectations over the next 1 to 2 years.”
• Margin guidance for EMS remains anchored around ~10–11% EBITDA (cost-plus model).
• Design-led manufacturing / system integration as a margin & differentiation lever:
• “Tightly integrating our engineering services and EMS teams” to enable “design-led manufacturing solutions,” targeting improved margin profiles and “first DLM program wins” in coming quarters.
• Capex/expansion signal (facility):
• KIADB Aerospace Park: design complete; construction starting soon; Centum expects capex flow end of next fiscal with total estimate INR 50–70 crores (but “this year… we don’t have to invest” per land structure).

3. Q&A Analysis

Theme A: BTS revenue recognition, execution cadence, and advances

• Core questions
• Will BTS revenue recognition accelerate given order book growth?
• How much of advances relates to BTS?
• Management response
• “The simple answer is yes… expect… strong growth in BTS revenue this year and the coming years,” while noting “quarterly variations” due to lumpiness.
• Advances: “majority…” and “about two-thirds” from BTS.
• Notable aspects
• Strong commitment on full-year BTS growth, but still hedged on quarter-to-quarter variability.

Theme B: Semiconductor equipment details, customers, margins, and growth shape

• Core questions
• What exactly is the semiconductor equipment business (customers, product scope)?
• What are margins and when does revenue contribute meaningfully?
• Is growth linear or exponential; is demand recurring?
• Competitive landscape in India vs other geographies; ability to serve other customers.
• Management response
• Product scope: EMS “box builds and PCBAs” for semiconductor manufacturing equipment OEMs.
• Customer: “a global OEM… added as a customer,” ramping part numbers/products.
• Revenue trajectory:
  • FY25 ~0 → FY26 >INR 100 crores → expect USD 25–30m in 1–2 years.
  • “double or triple in the next 2 years.”
• Margins: “range of about 10% EBITDA… cost-plus model.”
• Growth shape: steep ramp already; expects stabilization after 1–2 years, but “recurring demand.”
• Competition: “main supplier in India,” competition mainly in Southeast Asia (Malaysia).
• Customer exclusivity: design/IP belongs to customer; “not allowed to sell the same product to other players,” though preliminary discussions exist with other customers.
• Notable aspects
• Clear correction when asked about “higher margins in semiconductor” (management: semiconductor is still EMS; margin stays ~11%).
• Competition answer is unusually direct (“main supplier in India”)—high confidence but could be context-specific to the specific OEM/program.

Theme C: BTS/EMS mix and India growth/margin guidance

• Core questions
• Can BTS revenue mix sustainably move beyond ~70/30?
• Maintain India growth target of 25%+?
• FY27/FY28 revenue and margin guidance; export vs domestic split.
• Management response
• Mix: may be “marginally favorable towards BTS” but “not hugely drastically different.”
• India growth: “We will reach… confident of reaching 25% level.”
• Explicit guidance:
  • FY27 revenue growth: “about 25%”
  • Margins: last year ~12.5%; aiming “move it up and above about 13%,” stable/slightly improve next year.
  • Export composition: “50% to 55% or even slightly higher,” “nothing much expected to change.”
• Notable aspects
• Management gives more explicit FY27/FY28 direction than earlier calls, but still uses “as of now / too early” language for next year.

Theme D: Defense/space program progress (BTS initiatives)

• Core questions
• Update on Virupaksha, UHM, TACAN/TACAN-like systems; prototype timelines.
• Direct engagement with armed forces vs PSUs/DRDO/ISRO.
• Any new BTS initiatives not captured in slides.
• Management response
• Development progress:
  • UHM: first phase design reviews done; prototypes expected “in the next year,” then serial production after HAL review.
  • Virupaksha: design in progress; development orders completed “maybe in Q4 or Q1.”
  • TACAN: deliveries/development “beginning of next year”; monitoring for further orders.
• Armed forces: discussions/RFIs “in various levels of discussion,” will update when mature.
• New color: ramp-up of engineering talent and focus on “system integration.”
• Notable aspects
• Timelines are specific enough to be useful (prototype/deliveries next year), but still conditional (“expect,” “progressing well”).

Theme E: Capex / KIADB facility

• Core questions
• Status of construction and capex plans.
• Management response
• Design complete; construction “soon.”
• Centum does not invest this year because land belongs to another group entity.
• Capex estimate: INR 50–70 crores, with cash flow starting towards end of next fiscal.

4. Guidance / Outlook

Explicit guidance (quantitative)

• FY27 revenue growth (India/standalone): “about 25%” (maintained).
• FY27 margins (standalone EBITDA):
• Last year ~12.5%
• Aim “above about 13%,” “could remain stable or slightly improve” next year.
• Export composition (order mix): “50% to 55% or even slightly higher.”
• BTS revenue growth expectation: “strong growth… this year and the coming years” (no numeric figure, but affirmative).
• Capex (KIADB facility): total estimate INR 50–70 crores, with flow starting end of next fiscal; no Centum capex this year for this facility.

Implicit signals (qualitative)

• Q1 softness is temporary: management attributes muted growth/margins to “project execution and revenue phasing,” implying improved execution in subsequent quarters.
• BTS and EMS both have strong order intake: “continued strong order intake through the year” and EMS visibility to “surpass expectations over the next 1 to 2 years.”
• Margin structure likely constrained by EMS cost-plus model: semiconductor equipment margins expected to remain ~10–11% EBITDA.

5. Standout Statements (direct / revealing)

• On BTS revenue acceleration: “The simple answer is yes.”
• On overseas liabilities: “we do not expect any further liabilities in relation to these subsidiaries.”
• On Q1 softness cause: Q1 was “somewhat muted… primarily a function of… project execution and revenue phasing.”
• On semiconductor equipment margins: “margin stay at 11%” / “range of about 10% EBITDA… cost-plus model.”
• On semiconductor growth shape: “steep growth…” and expects stabilization “in the next maybe 1 to 2 years.”
• On FY27 guidance: “We will reach… 25% level” and margins “above about 13%.”
• On capex timing: “this year… we don’t have to invest anything… capex flow could start… towards the end of next fiscal.”

6. Red Flags / Positive Signals (Optional)

Positive signals
– Overseas restructuring de-risking: deconsolidation completed and management claims no further liabilities.
– Strong order inflows and order book growth across BTS and EMS.
– Semiconductor equipment business described as already in serial production with recurring demand.

Red flags
– Margin improvement narrative is still partly dependent on mix and execution (BTS phasing; EMS mix; DLM wins timing).
– Semiconductor “visibility” is strong, but management repeatedly anchors margins to cost-plus—upside may be limited.
– Some answers remain conditional/early-stage (e.g., export BTS global opportunity sizing; armed forces engagement maturity; next-year margin “too early” to comment precisely).

7. Historical Comparison & Consistency Analysis

a. Change in Tone Over Time

• Current call (Q1 FY27): More Optimistic
• Stronger confidence due to restructuring completion and clearer FY27 targets.
• Less emphasis on “we are evaluating options” for Europe; more “chapter behind us.”
• Prior calls:
• Q4 FY26 (May 15, 2026): optimistic but still in restructuring transition; margins discussed with mix issues.
• Q3 FY26 (Feb 16, 2026): candid about overseas challenges; still expecting court-driven outcomes and potential further exceptional items.
• Q2 H1 FY26 (Nov 13, 2025): more defensive on consolidated margins; subsidiary losses a key concern.
• Shift classification: More Optimistic (confidence + closure of overseas overhang).

b. Tracking Past Commitments vs Outcomes

• Past statement (Q4 FY26, May 15, 2026): restructuring “substantially concluded by July 2026” (France divestment process).
• What happened by Q1 FY27 call: French court approved acquisition; deconsolidation effective 4 June 2026; liquidation judiciaire appointed 2 July 2026.
• Assessment: ✅ Delivered (timing broadly aligned; deconsolidation occurred in June).
• Past statement (Q2 H1 FY26, Nov 13, 2025): Canada divestment/closure decision expected “by end of the quarter… in a few months.”
• What happened: Canada discontinued operations earlier; by Q1 FY27 call, overseas restructuring is largely completed and deconsolidation already effective for French entities; Canada is no longer a continuing overhang.
• Assessment: ✅ Delivered (Canada overhang removed; no longer discussed as a continuing risk).
• Past statement (Q4 FY26, May 15, 2026): margin guidance target standalone 13%–15% (combined level referenced earlier).
• What happened in Q1 FY27 call: management says Q1 margins muted; expects mix improvement as BTS execution accelerates. FY27 margin aim is “above about 13%.”
• Assessment: ⏳ Partially Delivered / Delayed (they did not claim mid-teens yet; still working toward >13% and execution/mix dependent).

c. Narrative Shifts

• Overseas risk narrative moved from “evaluation/turnaround” to “completed/behind us.”
• Q2/Q3 FY26: Europe macro/ER&D weakness and restructuring options were central.
• Q1 FY27: focus shifts to core India ESDM, with explicit “no further liabilities” language.
• Semiconductor narrative strengthened from “ramp-up” to “serial production + recurring demand + growth stabilization.”
• Margin narrative becomes more constrained/realistic:
• Earlier calls discussed margin improvement via mix/operating leverage.
• Now, EMS (including semiconductor equipment) margin is explicitly capped around ~10–11%; upside depends on design-led manufacturing/system integration and BTS mix.

d. Consistency & Credibility Signals

• High credibility on restructuring timeline: court-driven milestones appear to have been met broadly.
• Credibility on guidance: FY27 targets are reiterated (“25% growth,” “>13% margins”) and supported by order book/order inflow.
• Medium credibility on margin upside: management continues to attribute margin outcomes to mix/phasing; no hard commitment to mid-teens.

Overall credibility: Medium-High

e. Evolution of Key Themes

• Demand/order intake: Improving/strong and increasingly quantified (order inflow +70% YoY in Q1 FY27).
• Margins: Stable-to-improving but still execution/mix dependent; EMS margin floor reiterated.
• Expansion/system integration: Increasing emphasis on DLM and system integration as a path to margin improvement.
• Semiconductor equipment: From early ramp to “mature/serial production” with recurring demand.

f. Additional Insights (Cross-Period Intelligence)

• The company’s consolidated profitability in Q1 FY27 includes a one-time deconsolidation gain (INR 94 crores), while management simultaneously stresses that operating performance is still subject to BTS phasing. This can inflate headline PAT while underlying margin trajectory remains execution-dependent.
• Management’s semiconductor “visibility” is strong, but they also explicitly limit margin upside—suggesting that future earnings growth may be driven more by volume/order ramp than margin expansion in EMS.